G. J. Huchon (Paris, France), R. Wilson (London, United Kingdom)
Epstein Barr virus infection of the pleural space
A. Bossink, R. Luderer, J. V. Gorp, S. Thijsen (Utrecht, The Netherlands)
|  |
Pharmacokinetics and pharmacoynamics of clarithromycin in the empyema pleural fluid
I. E. Liapakis, M. S. Pitiakoudis, A. J. Karayiannakis, S. E. Constantinos, T. Thomas, K. Pantelis, D. E. Bouros (Alexandroupolis, Athens, Greece)
| |
Video-assisted thoracoscopic surgery (vats) in the treatment of parapneumonic empyema
A. Orki, H. Eryigit, H. Kiral, C. Aydemir, S. Urek, C. Tezel, M. Keles, B. Arman (Istanbul, Turkey)
| |
The efficacy of macrolides in the treatment of bronchiectasis colonised by Ps aeruginosa
H. Lode, M. Ioanas, A. Kuhnke, M. Allewelt (Berlin, Germany)
| |
Non CF-bronchiectasis in Greece: aetiologic approach, clinical and microbioligal profile of 115 cases
K. Dimakou, P. Bakakos, P. Dimakos, E. Vei, S. Kanavaki, A. Rasidakis, D. Orphanidou (Athens, Greece)
| |
Incidence of different pathogenic microorganisms and antibiotic susceptibility in a respiratory diseases unit
P. Ceruti, L. Ferrari, M. Anghinolfi, M. Betti, I. Stifani, G. Bosio (Cremona, Italy)
| |
Treatment of respiratory tract infections: comparison of telithromycin and azithromycin
J. P. Guggenbichler, G. Juhl (Erlangen, Germany)
| |
Respiratory infections in our experience: isolations and resistances
A. Tolisano, G. Malomo, W. Venditti, A. Bonifati, F. Tirone (Lungro, Castrovillari, Italy)
| |
Clinical evaluation of patients with acute exacerbation of chronic bronchitis treated emperically with telithromycin
A. A. Abu Hussein, A. R. Ads, M. El-Hamamsy (Tanta, Cairo, Egypt)
| |
Bacterial infections in patients with acute exacerbations of COPD
D. V. Todea, N. N. Ariesanu, V. V. Muresan, A. Parau, M. Simon (Cluj Napoca, Romania)
| |
The role of viruses as trigger factors for asthma exacerbation
S. Pejkovska, D. Dokic, S. Arbutina, D. Karkinski, Z. Arsovski (Skopje, Macedonia)
| |
Diagnostic importance of quantitative evaluation of plasma CRP in COPD
G. Ilonidis, G. Anogianakis, I. Giavazis, E. Theofilogiannakos, P. Glouftsios, A. Anogeianaki (Thessaloniki, Greece)
| |
Peculiarities of antibacterial therapy of respiratory infections in patients with bronchial asthma
N. F. Tumanova-Ponomareva, E. I. Shmelev (Moscow, Russia)
| |
LRT infections aetiology in hospitalized children and its importance for asthma exacerbation
L. Perovic, D. Djordjevic, S. Brankovic (Nis, Serbia & Montenegro)
| |
Immunomodulatory properties of macrolide antibiotics in the treatment of bronchial sepsis involving P. aeruginosa
A. L. Pukhalsky, G. V. Shmarina, N. I. Kapranov (Moscow, Russia)
| |
Pulmonary and sinus diseases in primary humoral immunodeficiencies
I. V. Sidorenko, S. A. Zenokhov (Moscow, Russia)
| |
Bronchial asthma and chlamydia pneumaniae associations
V. V. Chopyak, M. Mazur, K. O. Lishchuk-Jakymovych (Lviv, Ukraine)
| |
Audit on the MRSA infection in adults with cystic fibrosis
A. A. Ionescu, C. A. Davies, J. Jenkins, I. A. Campbell, D. J. Shale (Cardiff, Penarth, United Kingdom)
| |
Distribution of nebulised gentamicin in patients with bronchiectasis
A. C. Boyter, J. P. Fuld, R. D. Stevenson, C. G. Wilson (Glasgow, United Kingdom)
| |
The effect of erythromycin on the chronic lower airway infection by pseudomonas aeruginosa
H. Li, H. Yu, G. He (Shanghai, China)
| |